Date: 15.9.2021
Diabetic skin ulcers often take a long time to heal, sometimes even leading to complications that result in amputation. A new hydrogel is designed to help keep that from happening, by delivering oxygen directly to such wounds.
Developed by scientists at Missouri's Washington University in St. Louis, the substance initially takes the form of a liquid. It contains microspheres with a shell that incorporates the enzyme catalase. That shell in turn encases a core consisting of a blend of hydrogen peroxide and a water-soluble polymer.
Once applied to a skin ulcer and warmed by the patient's body heat, the liquid solidifies into a moist, flexible gel. The catalase in the spheres' shells then reacts with the hydrogen peroxide, causing it to be converted into molecular oxygen. This process continues over a two-week period, during which time the released oxygen reduces swelling and promotes the growth of new skin cells.
Additionally, the hydrogel is able to capture and destroy harmful chemicals known as reactive oxygen species (ROS), which can form when too much oxygen is applied to a wound. If ROS levels are particularly high, skin cells may die as a result.
In lab tests performed on diabetic mice, skin ulcers treated with the hydrogel – complete with its microspheres – were reduced to 10.7 percent their original size after 16 days. By contrast, ulcers treated with just the gel were reduced to 30.4 percent, and untreated ulcers shrank to 52.2 percent their original size.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Berkeley - University of California
Biotechnology company - list of biotechnology companies
At-home stress testing possible, thanks to nanoparticles
New modified CRISPR protein can fit inside virus used for gene therapy